Shilpa Medicare has received an approval to establish Whole Owned Subsidiary (WOS) each in Canada (North America) and Spain (Europe) for the business operations of the company. The Board of Directors of the company at its meeting held on May 5, 2020, has approved the same.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
